Contact Us
Drug Search Results
More Filters [+]

Iobitridol

Alternative Names: iobitridol
Latest Update: 2024-11-05
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Contrast Agent

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Algeria | Argentina | Austria | Belgium | Bosnia | Brazil | Chile | Colombia | Croatia | Czech | Denmark | Ecuador | Egypt | France | Germany | Greece | Hong Kong | Hungary | India | Ireland | Israel | Italy | Korea | Luxembourg | Malaysia | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Portugal | Romania | Russia | Saudi Arabia | Singapore | Slovenia | South Africa | Spain | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | United Arab Emirates | United Kingdom | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Guerbet
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Iobitridol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Hepatocellular Carcinoma|Other

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
Hepatic CT perfusion

P4

Completed

Hepatocellular Carcinoma

2015-12-18

ISO-44-009

P4

Completed

Other

2008-02-01

Recent News Events

Date

Type

Title

05/01/2024

PubMed

 Microvascular changes following exposure to iodinated contrast media in vitro. A qualitative comparison to serum creatinine concentrations in post-cardiac catheterization patients.

01/30/2024

PubMed

 Surface functionalization of endotracheal tubes coated with laccase-gadolinium phosphate hybrid nanoparticles for antibiofilm activity and contrasting properties.

01/01/2024

PubMed

 Good tolerance to iobitridol in a patient with sialadenitis induced by iohexol and iopromide: A case report.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions